Pattern-recognition receptor signaling regulator mRNA expression in humans and mice, and in transient inflammation or

Roman Günthner1, Vankayala Ramaiah Santhosh Kumar, Georg Lorenz

  • 1Medical Clinic and Policlinic IV, Nephrology Center, University of Munich, 80336 Munich, Germany. roman.guenthner@med.uni-muenchen.de

Insights

This study reveals significant differences in the expression of negative regulators of pattern-recognition receptors (PRRs) between humans and mice. These regulators are involved in innate immunity, tissue injury, and scarring.

Area of Science:

  • Immunology
  • Molecular Biology

Background:

  • Pattern-recognition receptors (PRRs) are crucial for innate immunity.
  • While PRR expression is well-studied, their negative regulators' expression profiles remain largely unknown.
  • Understanding these regulators is key to modulating immune responses.

Purpose of the Study:

  • To determine and compare the mRNA expression levels of various PRR negative regulators in human and mouse solid organs.
  • To investigate the expression of these regulators in mononuclear blood cells upon bacterial endotoxin stimulation.
  • To analyze the expression patterns during kidney ischemia-reperfusion injury and subsequent fibrosis in mice.

Main Methods:

  • Quantitative mRNA expression analysis of 22 PRR negative regulators.
  • Comparative analysis across human and mouse organs.
  • In vitro stimulation of human and murine mononuclear blood cells with bacterial endotoxin.
  • In vivo study of kidney ischemia-reperfusion injury model in mice.

Main Results:

  • Significant differences observed in mRNA expression patterns of PRR negative regulators between humans and mice.
  • Consistent induction of A20, SOCS3, IRAK-M, and Clec4a2 in both human and murine mononuclear cells after endotoxin exposure.
  • Multiple regulators (A20, CD180, ST2, SOCS1, SOCS3, SHIP, IRAK-M, DOK1, DOK2, IRF4, CENTB1, Clec4a2) were induced during kidney injury and repair, with persistent induction linked to fibrosis.

Conclusions:

  • Organ- and species-specific expression of PRR negative regulators must be considered in immunological studies.
  • These regulators play a role in innate immunity, tissue injury, regeneration, and progressive scarring.
  • Findings provide a basis for therapeutic strategies targeting PRR-mediated pathways in inflammatory conditions.

Related Concept Videos

Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Acute Inflammation I: Inflammatory Response01:26

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...